Fc fusion as a platform technology: potential for modulating immunogenicity
Author:
Publisher
Elsevier BV
Subject
Bioengineering,Biotechnology
Reference88 articles.
1. Beyond antibodies: using biological principles to guide the development of next-generation protein therapeutics;Kariolis;Curr. Opin. Biotechnol.,2013
2. Plasma derivatives: new products and new approaches;Sauna;Biologicals,2012
3. FcRn: the neonatal Fc receptor comes of age;Roopenian;Nat. Rev. Immunol.,2007
4. Receptor–Fc fusion therapeutics, traps, and MIMETIBODY technology;Huang;Curr. Opin. Biotechnol.,2009
5. Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies;Beck;MAbs,2011
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tailoring biomaterials for vaccine delivery;Journal of Nanobiotechnology;2024-08-12
2. Immunoglobulins: Mechanistic Approaches in Moderation of Various Inflammatory and Anti-Inflammatory Pathways;Current Pharmaceutical Biotechnology;2024-08-08
3. An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity;International Journal of Nanomedicine;2024-07
4. Human antibodies neutralizing the alpha-latrotoxin of the European black widow;Frontiers in Immunology;2024-06-12
5. Synergic Chemoimmunotherapy of Cervical Cancer by Combining Cisplatin with Thermosensitive Polypeptide Fused Interferon Alpha;Advanced Therapeutics;2024-06-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3